Baxter InternationalvsEli Lilly and Company

BAX and LLY stock compared: price, dividend, valuation and results, from SEC filings.

BAX

Baxter International Inc.

$25.76

Value $13.3B

-1.05%
BAX's page

LLY

Eli Lilly and Company

$1,415.55

Value $1.34T

-0.82%
LLY's page

Baxter International (BAX) has a market value of $13.3B and Eli Lilly and Company (LLY) $1.34T. Over the last year, with dividends, BAX moved +38.5% and LLY +40.5%. Dividend yield: BAX 0.16%, LLY 0.45%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BAX$13.3B

    LLY$1.34T

    LLY is 101 times BAX

  • Revenue, 12 months

    BAX$11.6B

    LLY$86.5B

    LLY is 7.4 times BAX

  • Net income, 12 months

    BAX-$723M

    LLY$27.6B

  • Operating margin

    BAX-1.9%

    LLY–

  • ROIC

    BAX-1.0%

    LLY35.5%

    36.5 points apart

  • P/E

    BAX–

    LLY48.4

  • Dividend yield

    BAX0.2%

    LLY0.4%

    0.3 points apart

  • 5-year return

    BAX-64.6%

    LLY+478.4%

    543.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BAX-64.6%

LLY+478.4%

020040060020222023202420252026
Returns by period
PeriodBAXWith dividendsLLYWith dividends
1 year since November 14, 2025+38.5%Price +38.3%+40.5%Price +39.6%
3 years since November 16, 2023-23.8%-8.7% a yearPrice -28.0%+148.1%+35.4% a yearPrice +143.2%
5 years since November 15, 2021-64.6%-18.7% a yearPrice -67.9%+478.4%+42.1% a yearPrice +454.0%
10 years since November 17, 2016-36.8%-4.5% a yearPrice -45.8%+2,043.0%+35.9% a yearPrice +1,742.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BAXBaxter InternationalLLYEli Lilly and Company

Valuation

BAXLLY
Valuation
Price$25.76$1,415.55
Market value$13.3B$1.34T
Enterprise value (EV)$21.6B$1.38T
P/E–48.4
P/E, 5-year median–49.9
P/B2.033.2
EV/EBIT–39.7
Free cash flow yield8.6%1.5%

Results and growth

BAXLLY
Results and growth
Revenue, 12 months$11.6B$86.5B
Net income, 12 months-$723M$27.6B
Free cash flow, 12 months$1.1B$19.7B
Earnings per share, 12 months-$1.42$30.81
Revenue growth, year on year5.7%44.7%
Revenue growth a year, past-0.8%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

BAXLLY
Margins and returns on capital
Gross margin30.1%83.6%
Operating margin-1.9%–
Net margin-6.2%31.9%
ROIC-1.0%35.5%
ROE-11.3%88.6%

Balance sheet

BAXLLY
Balance sheet
Cash$2.0B$4.9B
Total debt$10.5B$49.5B
Net debt / EBITDA11.01.2
Interest cover-0.8×38.9×

Dividends and buybacks

BAXLLY
Dividends and buybacks
Dividend yield0.2%0.4%
Dividend per share, 12 months$0.04$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield0.2%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BAX or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Baxter International or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.34T) is about 100.8 times Baxter International ($13.3B), at today's prices.

How did BAX and LLY stock do over the last 10 years?

Since November 17, 2016, BAX's price moved -45.8% and LLY's +1,742.3%. With dividends: BAX -36.8% (-4.5% a year), LLY +2,043.0% (+35.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, BAX or LLY?

The dividend yield at today's price is 0.16% for Baxter International and 0.45% for Eli Lilly and Company. Over the last twelve months they paid $0.04 and $6.34 per share.

Which has the higher profit margins, Baxter International or Eli Lilly and Company?

Over the last twelve months, the net margin was -6.2% for Baxter International and 31.9% for Eli Lilly and Company, and the operating margin -1.9% and –. Revenue was $11.6B and $86.5B.

Which is the better investment, Baxter International or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.